Yuhui Hao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuhui Hao has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
Juan Li
State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Army Medical University, Chongqing, China
20 shared publicationsYonghong Ran
State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine
19 shared publicationsYazhen Zhao
State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Army Medical University, Chongqing, China
18 shared publicationsShiyan Fu
State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Army Medical University, Chongqing, China
11 shared publicationsYong Li
State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Army Medical University, Chongqing, China
9 shared publicationsBinghui Lu
State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Army Medical University, No.30 Gaotanyan Street, Shapingba District, Chongqing 400038, China
8 shared publications
Latest Publications
- 11 July 2026
- Published by Springer Nature in BioMetals
- Vol. 39 (5) , 1399-1420
Recent advances in therapeutic agents for uranium poisoning: a comprehensive review
Uranium—an emerging pollutant that exhibits both radioactivity and heavy metal toxicity—is extensively used in nuclear fuel and military applications. Occupational and environmental exposure during its extraction, production, and utilization poses significant health risks. Consequently, developing effective countermeasures against uranium poisoning remains a critical challenge in the field of medical research. This review systematically introduces the latest experimental progress in research on drugs for treating uranium toxicity. It specifically elucidates the mechanisms and efficacy evaluations of multiple detoxification strategies, including chelating agents, nanomedicines, biosynthetic compounds, small molecules, natural medicines, and plant extracts. By analyzing innovative drug design principles and evaluating their mechanistic effects on uranium toxicity, this work provides critical insights for the future development of highly effective and low-toxicity novel therapies for uranium poisoning. Graphical abstract
- 11 July 2026
- Published by Springer Nature in BioMetals
- Vol. 39 (5) , 1399-1420
Recent advances in therapeutic agents for uranium poisoning: a comprehensive review
Uranium—an emerging pollutant that exhibits both radioactivity and heavy metal toxicity—is extensively used in nuclear fuel and military applications. Occupational and environmental exposure during its extraction, production, and utilization poses significant health risks. Consequently, developing effective countermeasures against uranium poisoning remains a critical challenge in the field of medical research. This review systematically introduces the latest experimental progress in research on drugs for treating uranium toxicity. It specifically elucidates the mechanisms and efficacy evaluations of multiple detoxification strategies, including chelating agents, nanomedicines, biosynthetic compounds, small molecules, natural medicines, and plant extracts. By analyzing innovative drug design principles and evaluating their mechanistic effects on uranium toxicity, this work provides critical insights for the future development of highly effective and low-toxicity novel therapies for uranium poisoning. Graphical abstract
- 25 June 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 219, 633-647
Acid-responsive bone-targeting nanoplatform enables spatiotemporal control of osteogenesis and angiogenesis for osteoporosis rescue
- 25 June 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 219, 633-647
Acid-responsive bone-targeting nanoplatform enables spatiotemporal control of osteogenesis and angiogenesis for osteoporosis rescue
- Open Access
- 19 May 2026
- Published by Springer Nature in npj Aging
- Vol. 12 (1)
Decidual aging in recurrent pregnancy Loss: from regulating networks to therapeutic interventions
.The uterine decidua is a key component of the maternal-fetal interface, and its senescence may be an important contributing factor to recurrent pregnancy loss (RPL). Decidual senescence disrupts gestational homeostasis via cell cycle arrest, immune imbalance, and metabolic reprogramming, thereby potentially contributing to RPL. This review offers a new paradigm for understanding RPL etiology, with significant clinical value for improving reproductive outcomes.
- 19 May 2026
- Published by Springer Nature in npj Aging
- Vol. 12 (1)
Open AccessDecidual aging in recurrent pregnancy Loss: from regulating networks to therapeutic interventions
.The uterine decidua is a key component of the maternal-fetal interface, and its senescence may be an important contributing factor to recurrent pregnancy loss (RPL). Decidual senescence disrupts gestational homeostasis via cell cycle arrest, immune imbalance, and metabolic reprogramming, thereby potentially contributing to RPL. This review offers a new paradigm for understanding RPL etiology, with significant clinical value for improving reproductive outcomes.
- 2 April 2026
- Published by Springer Nature in Inflammation Research
- Vol. 75 (1) , 86
Multifaceted regulation of immune cells in radiation-induced pulmonary fibrosis: from mechanistic insights to targeted therapies
Background Radiation induced pulmonary fibrosis (RIPF) is a life threatening and frequent complication that can occur after radiotherapy to thoracic cancers, and has a complicated pathogenesis and few treatment options. Recent data suggest that immune cells are the centerpiece of this mechanism, and constitute a complex system of regulation. Objective This review systematically summarizes the dynamic roles and molecular mechanisms of key immune cells in RIPF initiation and progression, and reviews current advances in targeted immunotherapies. Methods A comprehensive literature search was conducted in PubMed and Web of Science for studies on immune regulation and therapeutic strategies in RIPF. Results RIPF exhibits profound spatiotemporal heterogeneity, with immune cell subsets evolving dynamically from inflammation to fibrosis. Macrophages transcend the M1/M2 dichotomy, encompassing specialized subsets. Neutrophils promote fibrosis via NETosis and STAT3/NLRP3 pathways, while eosinophils switch from protective to pathogenic phenotypes. Beyond Th1/Th2 imbalance, Tregs and Th17 cells critically contribute to fibrosis. Emerging targeted strategies—including nanomaterials, natural compounds, and specific inhibitors—have shown promising preclinical results. Conclusion Understanding the spatiotemporally specific functions of immune cells is crucial for developing precision immunotherapies. Future research should focus on biomarker-guided combination strategies to transform RIPF into a preventable and manageable condition.
- 2 April 2026
- Published by Springer Nature in Inflammation Research
- Vol. 75 (1) , 86
Multifaceted regulation of immune cells in radiation-induced pulmonary fibrosis: from mechanistic insights to targeted therapies
Background Radiation induced pulmonary fibrosis (RIPF) is a life threatening and frequent complication that can occur after radiotherapy to thoracic cancers, and has a complicated pathogenesis and few treatment options. Recent data suggest that immune cells are the centerpiece of this mechanism, and constitute a complex system of regulation. Objective This review systematically summarizes the dynamic roles and molecular mechanisms of key immune cells in RIPF initiation and progression, and reviews current advances in targeted immunotherapies. Methods A comprehensive literature search was conducted in PubMed and Web of Science for studies on immune regulation and therapeutic strategies in RIPF. Results RIPF exhibits profound spatiotemporal heterogeneity, with immune cell subsets evolving dynamically from inflammation to fibrosis. Macrophages transcend the M1/M2 dichotomy, encompassing specialized subsets. Neutrophils promote fibrosis via NETosis and STAT3/NLRP3 pathways, while eosinophils switch from protective to pathogenic phenotypes. Beyond Th1/Th2 imbalance, Tregs and Th17 cells critically contribute to fibrosis. Emerging targeted strategies—including nanomaterials, natural compounds, and specific inhibitors—have shown promising preclinical results. Conclusion Understanding the spatiotemporally specific functions of immune cells is crucial for developing precision immunotherapies. Future research should focus on biomarker-guided combination strategies to transform RIPF into a preventable and manageable condition.
- Open Access
- 3 February 2026
- Published by Elsevier in SSRN Electronic Journal
Bioeliminable Gd-MOF@AuPt/Mel Nanocomposite for Augmented Radiotherapy by Inducing Apoptosis and Ferroptosis
Radiotherapy is a widely employed therapeutic modality for tumor management; however, high radiation doses can induce deleterious effects in adjacent normal tissues, while tumor hypoxia and intrinsic radioresistance significantly impair treatment outcomes.To address these challenges, a gadolinium-based metal–organic framework (Gd-MOF) was synthesized via solvothermal methodology, followed by the construction of an acid-responsive multifunctional nanoplatform (MPAM). This platform integrates in situ-grown AuPt nanoparticles and electrostatically adsorbed melittin, thereby establishing dual radiosensitization mechanisms encompassing both physical and biochemical pathways. MPAM augments X-ray energy deposition within tumor tissue and induces pH-responsive release of its therapeutic payload. Mechanistically speaking, AuPt nanoparticles manifest dual peroxidase- and catalase-like enzymatic activities, catalyzing the conversion of H2O2 into O2 and highly reactive hydroxyl radicals (•OH), respectively. This process consequently alleviates tumor hypoxia, amplifies oxidative stress, disrupts cellular iron homeostasis, and enhances Fe2+ bioavailability, thereby inducing Fenton reactions and ferroptosis.Meanwhile, melittin disrupts mitochondrial membrane potential, activates the caspase-3 apoptotic pathway, and thereby augments mitochondrion-mediated apoptosis.Both in vitro and in vivo studies collectively demonstrate that MPAM markedly enhances DNA damage, suppresses tumor growth, and exhibits efficient tumor accumulation while maintaining a favorable biosafety profile.Collectively, this study demonstrates a safe, efficient radiosensitization strategy integrating physical dose enhancement with biological response potentiation, underscoring its translational potential for breast cancer radiotherapy.
- 3 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessBioeliminable Gd-MOF@AuPt/Mel Nanocomposite for Augmented Radiotherapy by Inducing Apoptosis and Ferroptosis
Radiotherapy is a widely employed therapeutic modality for tumor management; however, high radiation doses can induce deleterious effects in adjacent normal tissues, while tumor hypoxia and intrinsic radioresistance significantly impair treatment outcomes.To address these challenges, a gadolinium-based metal–organic framework (Gd-MOF) was synthesized via solvothermal methodology, followed by the construction of an acid-responsive multifunctional nanoplatform (MPAM). This platform integrates in situ-grown AuPt nanoparticles and electrostatically adsorbed melittin, thereby establishing dual radiosensitization mechanisms encompassing both physical and biochemical pathways. MPAM augments X-ray energy deposition within tumor tissue and induces pH-responsive release of its therapeutic payload. Mechanistically speaking, AuPt nanoparticles manifest dual peroxidase- and catalase-like enzymatic activities, catalyzing the conversion of H2O2 into O2 and highly reactive hydroxyl radicals (•OH), respectively. This process consequently alleviates tumor hypoxia, amplifies oxidative stress, disrupts cellular iron homeostasis, and enhances Fe2+ bioavailability, thereby inducing Fenton reactions and ferroptosis.Meanwhile, melittin disrupts mitochondrial membrane potential, activates the caspase-3 apoptotic pathway, and thereby augments mitochondrion-mediated apoptosis.Both in vitro and in vivo studies collectively demonstrate that MPAM markedly enhances DNA damage, suppresses tumor growth, and exhibits efficient tumor accumulation while maintaining a favorable biosafety profile.Collectively, this study demonstrates a safe, efficient radiosensitization strategy integrating physical dose enhancement with biological response potentiation, underscoring its translational potential for breast cancer radiotherapy.
- 7 November 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (2) , 465-474
Depleted uranium exposure induced ferroptosis in renal cells via the ETHE1/P38-MAPK pathway
This study investigated the role of ferroptosis in acute depleted uranium (DU)-induced nephrotoxicity. Using Sprague–Dawley rats and HK-2 cells to establish models of acute DU exposure (rats: 10 mg/kg; cells: 500 μM for 24 h), we found that DU exposure caused mitochondrial dysfunction, lipid peroxidation, and iron accumulation, all hallmarks of ferroptosis, which were inhibited by ferrostatin-1 (Fer-1). We identified mitochondrial ethylmalonic encephalopathy 1 (ETHE1) as a key DU target. ETHE1 downregulation exacerbated DU-induced reactive oxygen species (ROS), ferrous ions (Fe2+) overload and ferroptosis, while exogenous ETHE1 protein alleviated them. Furthermore, DU-triggered ROS activated the p38 mitogen-activated protein kinase (P38-MAPK) pathway, an effect enhanced by ETHE1 knockdown. Inhibiting P38-MAPK with adezmapimod (SB203580) suppressed ferroptosis and autophagy, and reduced the expression of nuclear receptor coactivator 4 (NCOA4), a mediator of ferritinophagy. Knockdown of NCOA4 also attenuated ferroptosis. In conclusion, acute DU exposure downregulates ETHE1, promoting mitochondrial ROS that activates P38-MAPK signaling. This pathway induces NCOA4-mediated ferritinophagy, ultimately leading to renal cell ferroptosis. These findings elucidate a novel mechanism for DU-induced kidney injury.
- 7 November 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (2) , 465-474
Depleted uranium exposure induced ferroptosis in renal cells via the ETHE1/P38-MAPK pathway
This study investigated the role of ferroptosis in acute depleted uranium (DU)-induced nephrotoxicity. Using Sprague–Dawley rats and HK-2 cells to establish models of acute DU exposure (rats: 10 mg/kg; cells: 500 μM for 24 h), we found that DU exposure caused mitochondrial dysfunction, lipid peroxidation, and iron accumulation, all hallmarks of ferroptosis, which were inhibited by ferrostatin-1 (Fer-1). We identified mitochondrial ethylmalonic encephalopathy 1 (ETHE1) as a key DU target. ETHE1 downregulation exacerbated DU-induced reactive oxygen species (ROS), ferrous ions (Fe2+) overload and ferroptosis, while exogenous ETHE1 protein alleviated them. Furthermore, DU-triggered ROS activated the p38 mitogen-activated protein kinase (P38-MAPK) pathway, an effect enhanced by ETHE1 knockdown. Inhibiting P38-MAPK with adezmapimod (SB203580) suppressed ferroptosis and autophagy, and reduced the expression of nuclear receptor coactivator 4 (NCOA4), a mediator of ferritinophagy. Knockdown of NCOA4 also attenuated ferroptosis. In conclusion, acute DU exposure downregulates ETHE1, promoting mitochondrial ROS that activates P38-MAPK signaling. This pathway induces NCOA4-mediated ferritinophagy, ultimately leading to renal cell ferroptosis. These findings elucidate a novel mechanism for DU-induced kidney injury.
- Open Access
- 29 May 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (7) , 3055-3056
Correction: Mitigation of depleted uranium-induced mitochondrial damage by ethylmalonic encephalopathy 1 protein via modulation of hydrogen sulfide and glutathione pathways
- 29 May 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (7) , 3055-3056
Open AccessCorrection: Mitigation of depleted uranium-induced mitochondrial damage by ethylmalonic encephalopathy 1 protein via modulation of hydrogen sulfide and glutathione pathways